These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 24184034)
1. Parenteral formulation of larotaxel lipid microsphere tackling poor solubility and chemical instability. Teng F; Yang H; Li G; Lin X; Zhang Y; Tang X Int J Pharm; 2014 Jan; 460(1-2):212-9. PubMed ID: 24184034 [TBL] [Abstract][Full Text] [Related]
2. A lipid microsphere vehicle for vinorelbine: Stability, safety and pharmacokinetics. Zhang HY; Tang X; Li HY; Liu XL Int J Pharm; 2008 Feb; 348(1-2):70-9. PubMed ID: 17719191 [TBL] [Abstract][Full Text] [Related]
3. Improving cabazitaxel chemical stability in parenteral lipid emulsions using cholesterol. Shao Y; Zhang C; Yao Q; Wang Y; Tian B; Tang X; Wang Y Eur J Pharm Sci; 2014 Feb; 52():1-11. PubMed ID: 24153395 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tissue distribution of larotaxel in rats: comparison of larotaxel-loaded microsphere with larotaxel-solution. Liu Z; Feng Y; Zhang L; Li G; Geng L; Cui Y; Teng F; Tang X; Bi K; Chen X Cancer Chemother Pharmacol; 2013 May; 71(5):1131-9. PubMed ID: 23412629 [TBL] [Abstract][Full Text] [Related]
5. [Preparation and in vitro and in vivo evaluation of etoposide submicro-emulsion for intravenous injection]. Tian LL; Tang X; He HB; Wang J Yao Xue Xue Bao; 2007 Aug; 42(8):892-7. PubMed ID: 17944242 [TBL] [Abstract][Full Text] [Related]
6. Formulation, stability and degradation kinetics of intravenous cinnarizine lipid emulsion. Shi S; Chen H; Cui Y; Tang X Int J Pharm; 2009 May; 373(1-2):147-55. PubMed ID: 19429300 [TBL] [Abstract][Full Text] [Related]
7. Formulation, preparation and evaluation of flunarizine-loaded lipid microspheres. Wang YJ; Wang J; Zhang HY; He HB; Tang X J Pharm Pharmacol; 2007 Mar; 59(3):351-7. PubMed ID: 17331337 [TBL] [Abstract][Full Text] [Related]
8. Stability and degradation kinetics of etoposide-loaded parenteral lipid emulsion. Tian L; He H; Tang X J Pharm Sci; 2007 Jul; 96(7):1719-28. PubMed ID: 17503537 [TBL] [Abstract][Full Text] [Related]
9. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies. Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546 [TBL] [Abstract][Full Text] [Related]
10. A parenteral docetaxel-loaded lipid microsphere with decreased 7-epidocetaxel conversion in vitro and in vivo. Luo L; Wang X; Chen Q; Miao L; Zhuo X; Liu L; Xu J; Zhang Y; He H; Yin T; Tang X Eur J Pharm Sci; 2017 Nov; 109():638-649. PubMed ID: 28918930 [TBL] [Abstract][Full Text] [Related]
11. Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax microspheres. Adeyeye CM; Price JC J Microencapsul; 1997; 14(3):357-77. PubMed ID: 9147285 [TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical development and manufacturing of a parenteral formulation of a novel antitumor agent, VNP40101M. Krishna G; Hodnick WF; Lang W; Lin X; Karra S; Mao J; Almassian B AAPS PharmSciTech; 2001 Aug; 2(3):E14. PubMed ID: 14727873 [TBL] [Abstract][Full Text] [Related]
13. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization. Xu H; Zhong H; Liu M; Xu C; Gao Y Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119 [TBL] [Abstract][Full Text] [Related]
14. Formulation and evaluation of nimodipine-loaded lipid microspheres. Yu J; He HB; Tang X J Pharm Pharmacol; 2006 Nov; 58(11):1429-35. PubMed ID: 17132204 [TBL] [Abstract][Full Text] [Related]
15. Long-term stability of morphine hydrochloride in 0.9% NaCl infusion polyolefin bags after freeze-thaw treatment and in polypropylene syringes at 5 degrees C + 3 degrees C. Hecq JD; Godet M; Gillet P; Jamart J; Galanti L Int J Pharm Compd; 2014; 18(1):78-82. PubMed ID: 24881344 [TBL] [Abstract][Full Text] [Related]
16. Formulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complex. Xia XJ; Guo RF; Liu YL; Zhang PX; Zhou CP; Jin DJ; Wang RY Chem Pharm Bull (Tokyo); 2011; 59(3):321-6. PubMed ID: 21372412 [TBL] [Abstract][Full Text] [Related]
17. Development of ligustrazine-loaded lipid emulsion: formulation optimization, characterization and biodistribution. Wei L; Marasini N; Li G; Yong CS; Kim JO; Quan Q Int J Pharm; 2012 Nov; 437(1-2):203-12. PubMed ID: 22944305 [TBL] [Abstract][Full Text] [Related]
18. A less irritant norcantharidin lipid microspheres: formulation and drug distribution. Lixin W; Haibing H; Xing T; Ruiying S; Dawei C Int J Pharm; 2006 Oct; 323(1-2):161-7. PubMed ID: 16828998 [TBL] [Abstract][Full Text] [Related]
19. Formulation and shelf life stability of water-borne lecithin nanoparticles for potential application in dietary supplements field. Edris AE J Diet Suppl; 2012 Sep; 9(3):211-22. PubMed ID: 22891991 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and tissue distribution of larotaxel in rats: comparison of larotaxel solution with larotaxel-loaded folate receptor-targeting amphiphilic copolymer-modified liposomes. Lu XF; Zhou Y; Zhang J; Wang GQ Xenobiotica; 2017 May; 47(5):416-422. PubMed ID: 27324077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]